-
381
Mesenchymal Stem Cells and Tissue Bioengineering Applications in Sheep as Ideal Model
Published 2024-01-01“…This review aimed to describe recent MSC approaches, including those associated with biomaterials, from experimental, clinical, and preclinical studies with sheep models.…”
Get full text
Article -
382
Generating unseen diseases patient data using ontology enhanced generative adversarial networks
Published 2025-01-01“…This innovative approach addresses the scarcity of data for rare diseases, offering valuable applications in data augmentation, hypothesis generation, and preclinical validation of clinical models.…”
Get full text
Article -
383
The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds)
Published 2017-01-01“…The promising results derived from the use of adipose-derived stem cells (ADSCs) in many diseases are a subject of observation in preclinical studies. ADSCs seem to be the ideal cell population for the use in regenerative medicine due to their easy isolation, nonimmunogenic properties, multipotential nature, possibilities for differentiation into various cell lines, and potential for angiogenesis. …”
Get full text
Article -
384
Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
Published 2025-01-01“…TIM-3 and LAG-3), have shown potential to reverse NK cell exhaustion in preclinical studies. This article explores the promise of these innovative strategies in HCC immunotherapy, providing new therapeutic directions for optimizing NK cell function and improving drug sensitivity.…”
Get full text
Article -
385
The Impact of the Myeloid Response to Radiation Therapy
Published 2013-01-01“…Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. …”
Get full text
Article -
386
Colorectal Polyposis and Immune-Based Therapies
Published 2004-01-01“…A broad spectrum of new treatments, including innovative molecular therapies such as gene therapy and treatment with cytokines, is under experimental and preclinical investigation. Nonsteroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors have traditionally been used as inflammation-reducing agents in cases of colon adenoma. …”
Get full text
Article -
387
Corneal Stem Cells as a Source of Regenerative Cell-Based Therapy
Published 2020-01-01“…Until now, various approaches and methods for isolation of LESCs and CSSCs and their successful transplantation have been described and tested in several preclinical studies and clinical trials. This review describes in detail phenotypic characteristics of LESCs and CSSCs and discusses their therapeutic potential in corneal regeneration. …”
Get full text
Article -
388
Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy
Published 2016-01-01“…The paper presents current evidence on the properties of human umbilical cord-derived mesenchymal stem cells, including origin, proliferative potential, plasticity, stability of karyotype and phenotype, transcriptome, secretome, and immunomodulatory activity. A review of preclinical studies and clinical trials using this cell type is performed. …”
Get full text
Article -
389
Within-session habituation and salivary cortisol during exposure treatment in obsessive-compulsive disorder – A link and an influence of DHEA?
Published 2024-12-01“…Background: Glucocorticoids increase fear extinction in preclinical and human studies. Endogenous cortisol might influence who will benefit from exposure therapy in anxiety-spectrum disorders. …”
Get full text
Article -
390
Commentary to F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There?
Published 2018-01-01“…This commentary describes the current status of GPIIb/IIIa-based PET imaging approaches with a focus on the recently published preclinical data of the small-molecule PET tracer 18 F-GP1. …”
Get full text
Article -
391
Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
Published 2004-01-01“…The inhibitors against the specific RTKs are in various preclinical and clinical trials, and this will be detailed.…”
Get full text
Article -
392
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
Published 2024-01-01“…This review provides a comprehensive summary of current clinical and preclinical evidence concerning ECS alterations in PD, along with potential pharmacological targets that may exert the protection of dopaminergic neurons.…”
Get full text
Article -
393
Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration
Published 2017-01-01“…This has been supported by preclinical studies and clinical trials investigating G-CSF as a potential therapeutic agent in relevant disease states. …”
Get full text
Article -
394
Comprehensive Guide to Randomized Controlled Trials in Radiology: Everything You Need to Know
Published 2025-01-01“…RCTs are vital in radiology for evaluating new imaging technologies, contrast agents, and therapeutic procedures, despite challenges in translating preclinical findings to clinical practice. This guide discusses the history, principles, methodologies, and applications of RCTs in radiology, highlighting their role in advancing the field and supporting evidence-based practice.…”
Get full text
Article -
395
Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
Published 2023-01-01“…Interleukin-2 has become a prominent focus of preclinical and clinical investigation, because of its known clinical activity, the important role of this cytokine in immune biology, and the ability to engineer variant proteins with potentially improved antitumor immunomodulatory activity and reduced toxicity. …”
Get full text
Article -
396
Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors
Published 2022-03-01“…The current paper proposes an extensive, up-to-date review of the preclinical and clinical development of glasdegib. Elements of its routine clinical use and the landscape of ongoing clinical trials are also stated.…”
Get full text
Article -
397
Inflammatory Mechanisms of Organ Crosstalk during Ischemic Acute Kidney Injury
Published 2012-01-01“…Kidney ischemia-reperfusion injury (IRI) incites a proinflammatory cascade and releases cellular and soluble mediators with systemic implications for remote organ injury. Evidence from preclinical models cites mechanisms of organ crosstalk during ischemic AKI including the expression of cellular adhesion molecules, lymphocyte trafficking, release of proinflammatory cytokines and chemokines, and modification of the host innate and adaptive immune response systems. …”
Get full text
Article -
398
Clinical and genetic characteristics and medical approach in attenuated form of familial adenomatosis of the colon
Published 2011-05-01“…At attenuated form mutation in АРС gene occurred within 450 and 510 codons and on the edges of this gene that allows both to reveal disease at preclinical stage, and to identify the attenuated variant. …”
Get full text
Article -
399
X-Ray Phase-Contrast Imaging with Three 2D Gratings
Published 2008-01-01“…X-ray imaging is of paramount importance for clinical and preclinical imaging but it is fundamentally restricted by the attenuation-based contrast mechanism, which has remained essentially the same since Roentgen's discovery a century ago. …”
Get full text
Article -
400
Expanding the therapeutic horizon in acute myeloid leukemia: The role of phosphoinositide-3-kinase-γ inhibition
Published 2024-12-01“…This study investigates the role of phosphoinositide-3-kinase-γ (PI3Kγ) in AML and explores the therapeutic potential of the PI3Kγ inhibitor, eganelisib, in preclinical models. Using genome-wide CRISPR interference screening, we identified PI3Kγ as a critical survival pathway in certain AML subsets. …”
Get full text
Article